Skip to content
Search

Latest Stories

Top Stories

Intelligence whistleblowers often pay a severe price

Intelligence whistleblowers often pay a severe price

"Former Army intelligence analyst Chelsea Manning has spent years in federal prison for releasing classified documents regarding U.S. military operations in Iraq and Afghanistan," writes Jennifer M. Pacella.

Win McNamee/Getty Images

Pacella is an assistant professor of business law and ethics at Indiana University.

When President Donald Trump likened a whistleblower's White House sources to spies and made a lightly veiled reference to execution, he highlighted a longstanding peril facing those who come forward to alert the public to governmental wrongdoing.

In many instances, whistleblowers find the abusive power they have revealed turned against them, both ending their careers and harming their personal lives.

In the private sector, whistleblowers are often ignored and told their concern is not part of their job description – and are commonly retaliated against by being demoted or fired.

When a whistleblower is in the U.S. intelligence and national security sphere, they're often speaking out about misdeeds by powerful figures – and, as a result, have frequently faced death threats, physical attacks, prosecution and prison.


The new whistleblower report that alleges wrongdoing by the president is a reminder of the vital importance of holding wrongdoers accountable, regardless of their level of power. When those acts affect national security, whistleblowing is even more important. But as I've found in my whistleblowing research, whistleblowers in this arena have far fewer legal protections from retaliation than those in corporate settings or elsewhere in government.

The consequences for government whistleblowers in the last 20 years have been harsh, in part because laws about classified information have made it difficult for people to publicize wrongdoing on sensitive issues.

After William Binney and J. Kirk Wiebe alleged in 2002 that their employer, the National Security Agency, mismanaged intelligence-gathering software that potentially could have prevented 9/11, their homes were raided and ransacked by the FBI as their families watched. Ultimately, the NSA revoked their security clearances and they were forced to sue to recover the confiscated personal property.

Another NSA whistleblower, Thomas Drake, alleged in 2002 that the agency's mass-surveillance programs after 9/11 involved fraud, waste and violations of citizens' rights. He became the subject of one of the biggest government leak investigations of all time and was prosecuted for espionage, which he ultimately settled through a plea agreement.

A third NSA whistleblower, Edward Snowden has spent years in exile, fearing an unfair trial should he return to the U.S.

Former Army intelligence analyst Chelsea Manning has spent years in federal prison for releasing classified documents regarding U.S. military operations in Iraq and Afghanistan.

Difficult consequences can come not just from the government but also from the public and the media. The New York Times has come under criticism for revealing identifying details about the current whistleblower's position.

Most laws governing federal whistleblowers lay out a procedure for coming forward with concerns, offer protections for confidentiality, and prevent recipients of information from harassing, threatening, demoting, firing or discriminating against the person raising the complaint.

Whistleblowers reporting securities law violations to the Securities and Exchange Commission have those protections. So do whistleblowers who report on fraudulent billing or claims against the government, such as Medicare or Medicaid fraud.

It can be difficult to find a balance between the government's need to protect highly sensitive classified information and the public's interest in uncovering wrongdoing. As a result, protections for whistleblowers in the intelligence community lack robust protections. The Intelligence Community Whistleblower Protection Act of 1998 outlines a process for whistleblowers in the intelligence community to raise concerns, but doesn't explicitly protect the whistleblower from retaliation or being publicly identified. Two executive-branch directives, created during the Obama administration, do bar retaliation against whistleblowers. However, they create a conflict of interest, because the person who determines whether there has been retaliation may be the person doing the retaliating.

Those Obama-era directives also prevent the whistleblower from seeking an independent court's review. They do not specify whether and exactly how aggrieved whistleblowers are entitled to back pay or reinstatement of employment, which are common whistleblower remedies.

It's no surprise, then, that in the first 10 years after the Intelligence Community Whistleblower Protection Act was enacted, no intelligence whistleblower was compensated for retaliation. While there have been no subsequent inquiries or information to determine whether intelligence whistleblowers have fared better since 2009, the law as it stands makes it nearly impossible for them to be protected.

Whistleblowers bring much-needed attention to matters of interest and importance to the public. Their courage – and willingness to face professional and personal peril – helps bring to light information that others would prefer to keep secret. That helps society as a whole fight injustice, waste, corruption and abuse of power, rather than passively and blindly accepting it.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

Read More

The Battle Over Truth: Trump, Data, and the Fight for Reality
File:Donald Trump (29496131773).jpg - Wikimedia Commons

The Battle Over Truth: Trump, Data, and the Fight for Reality

I. The Battle Over Facts

When Donald Trump fired Dr. Kristine Joy Suh, head of the Bureau of Labor Statistics, after a disappointing July jobs report, it wasn’t merely a personnel decision—it was a sharp break with precedent. Suh’s removal upended decades of tradition in which BLS commissioners, regardless of who appointed them, were shielded from political retaliation to preserve statistical integrity. In his second term, Trump has made it clear that data isn’t merely information to be reported—it’s a narrative to be controlled. If the numbers align with his message, they’re hailed as proof of success. If they don’t, they’re dismissed as fake—or worse, subversive.

Keep ReadingShow less
Time to Toughen Up: Democrats Face a Crossroads

Democrats Donkey lifts weights

Time to Toughen Up: Democrats Face a Crossroads

As the 2026 midterms loom, a simmering debate within Democratic circles has reached a boiling point: Should the party abandon the moral high ground and play political hardball?

In recent years, Democrats have leaned heavily on the ethos of civility and hope—famously embodied by Michelle Obama’s 2016 rallying cry, “When they go low, we go high.” But with the GOP embracing increasingly combative rhetoric and tactics, some strategists argue it’s time for Democrats to recalibrate their messaging—and their muscle.

Keep ReadingShow less
Trump’s Drug Price Ultimatum and the Rise of Enemy Politics
shallow focus photography of prescription bottle with capsules

Trump’s Drug Price Ultimatum and the Rise of Enemy Politics

In an era increasingly defined by transactional politics, the rhetoric of ultimatum has become one of President Donald Trump's favorite tools. When he declared to pharmaceutical giants on August 1st, "We will deploy every tool in our arsenal" should they fail to lower drug prices, it echoed a familiar pattern of the use of "demand" to shift from negotiation to confrontation. Trump's all-too-familiar pattern of prescribing with deadlines, threats of tariffs or sanctions, and appeals to fairness or national pride.

In his letter to 17 major drug manufacturers, Trump demanded that drug manufacturers slash prices to match "most favored nation" levels—the lowest rates offered in other developed countries. He emphasized that Americans are "demanding lower drug prices and they need them today." His language, though cloaked in populist concern, carried a veiled threat:

Keep ReadingShow less